- Home
- THAR vs LFT Comparison
THAR vs LFT Comparison
Compare THAR & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | THAR | LFT |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.8M | 75.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | THAR | LFT |
|---|---|---|
| Price | $3.05 | $1.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 531.4K | 252.8K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 11.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $21,708,246.00 |
| Revenue This Year | N/A | $124.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.34 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $1.35 |
| 52 Week High | $9.08 | $2.84 |
Technical Indicators
Market Signals| Indicator | THAR | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 38.60 |
| Support Level | $2.20 | $1.44 |
| Resistance Level | $3.56 | $1.52 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 63.60 | 15.56 |
Price Performance
Historical ComparisonAbout THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.